ZYLOXTB executes HKD 1.10 million share buyback, raising treasury stock to 10.94 million shares

Bulletin Express

Jun 08

Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a repurchase of 57,500 H-shares on 8 June 2026, acquiring the stock on the Hong Kong Stock Exchange at prices between HKD 18.96 and HKD 19.57 per share. The transaction totalled HKD 1.10 million based on a volume-weighted average price of HKD 19.18 per share.

Following the repurchase, ZYLOXTB’s outstanding share count (excluding treasury shares) decreased by 0.0173 % to 325.41 million, while treasury shares rose to 10.94 million. The company’s total issued share capital remains at 336.35 million shares.

The buyback forms part of the mandate approved by shareholders on 13 May 2026, which authorises the company to repurchase up to 32.72 million shares. Including the latest transaction, ZYLOXTB has repurchased 1.80 million shares under this mandate, representing 0.54 % of the issued share base at the date the authority was granted.

Under Hong Kong listing rules, the company is subject to a 30-day moratorium on issuing new shares or selling treasury shares, effective until 8 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1183138968"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1183138968\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1183138968?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-08 18:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183138968","market":"us","top_or_hot":-1,"title":"ZYLOXTB executes HKD 1.10 million share buyback, raising treasury stock to 10.94 million shares","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a repurchase of 57,500 H-shares on 8 June 2026, acquiring the stock on the Hong Kong Stock Exchange at prices between HKD 18.96 and HKD 19.57 per share. The transaction totalled HKD 1.10 million based on a volume-weighted average price of HKD 19.18 per share.</p>\n<p>Following the repurchase, ZYLOXTB’s outstanding share count (excluding treasury shares) decreased by 0.0173 % to 325.41 million, while treasury shares rose to 10.94 million. The company’s total issued share capital remains at 336.35 million shares.</p>\n<p>The buyback forms part of the mandate approved by shareholders on 13 May 2026, which authorises the company to repurchase up to 32.72 million shares. Including the latest transaction, ZYLOXTB has repurchased 1.80 million shares under this mandate, representing 0.54 % of the issued share base at the date the authority was granted.</p>\n<p>Under Hong Kong listing rules, the company is subject to a 30-day moratorium on issuing new shares or selling treasury shares, effective until 8 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ZYLOXTB executes HKD 1.10 million share buyback, raising treasury stock to 10.94 million shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZYLOXTB executes HKD 1.10 million share buyback, raising treasury stock to 10.94 million shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-08 18:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a repurchase of 57,500 H-shares on 8 June 2026, acquiring the stock on the Hong Kong Stock Exchange at prices between HKD 18.96 and HKD 19.57 per share. The transaction totalled HKD 1.10 million based on a volume-weighted average price of HKD 19.18 per share.</p>\n<p>Following the repurchase, ZYLOXTB’s outstanding share count (excluding treasury shares) decreased by 0.0173 % to 325.41 million, while treasury shares rose to 10.94 million. The company’s total issued share capital remains at 336.35 million shares.</p>\n<p>The buyback forms part of the mandate approved by shareholders on 13 May 2026, which authorises the company to repurchase up to 32.72 million shares. Including the latest transaction, ZYLOXTB has repurchased 1.80 million shares under this mandate, representing 0.54 % of the issued share base at the date the authority was granted.</p>\n<p>Under Hong Kong listing rules, the company is subject to a 30-day moratorium on issuing new shares or selling treasury shares, effective until 8 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1183138968","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183138968","pubTimestamp":1780912976,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a repurchase of 57,500 H-shares on 8 June 2026, acquiring the stock on the Hong Kong Stock Exchange at prices between HKD 18.96 and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"ZYLOXTB执行110万港元股份回购，库存股增至1094万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a repurchase of 57,500 H-shares on 8 June 2026, acquiring the stock on the Hong Kong Stock Exchange at prices between HKD 18.96 and HKD 19.57 per share. The transaction totalled HKD 1.10 million based on a volume-weighted average price of HKD 19.18 per share.\nFollowing the repurchase, ZYLOXTB’s outstanding share count (excluding treasury shares) decreased by 0.0173 % to 325.41 million, while treasury shares rose to 10.94 million. The company’s total issued share capital remains at 336.35 million shares.\nThe buyback forms part of the mandate approved by shareholders on 13 May 2026, which authorises the company to repurchase up to 32.72 million shares. Including the latest transaction, ZYLOXTB has repurchased 1.80 million shares under this mandate, representing 0.54 % of the issued share base at the date the authority was granted.\nUnder Hong Kong listing rules, the company is subject to a 30-day moratorium on issuing new shares or selling treasury shares, effective until 8 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}